Home > Company Introduction
Company Overview
Foerhao is a leading global partner to the pharmaceutical, food and health-care companies. The company is specialized in producing PET, PE, and PP bottles. The company is located in Tianjin, which is 85 km far from Tianjin Port and 100km far from Beijing Airport. We focus on R&D, design, production, sales and service for pharmaceutical packaging. We have 20000㎡ D-class clean room for pharmaceutical packing. We are approved by China food and drug administration, and we are High-Technology cooperation in Tianjin.
-
ManufacturerBusiness Type
-
2011Year Established
-
10,000-30,000 square metersFactory Size
-
US$50 Million - US$100 MillionAnnual Export Value
Company Detail
Transparency is the foundation of our partnership. Below is a comprehensive overview of our operational metrics, from business scale to global market reach, giving you a clear picture of our capabilities.
-
301 - 500 People Total Employees
-
Above 100 People Sales Staff
-
10-20 People Quality Inspectors
-
ISO9001 Product Certifications
-
US$50 Million - US$100 Million Annual Export Value
-
North America, South America, Eastern Europe, Oceania, Eastern Asia, Western Europe, Central America, Northern Europe, Southern Europe, South Asia Main Markets
-
Tianjin Port of Shipment
-
Beverage Bottle Main Industry
-
Our ServicesAccording to your requirements, mold manufacturers will use CAD or SolidWorks to produce 2D or 3D drawings. They show you different kinds of suggestions beyond your imagination. And then it’s our pleasure to use 3D print to make a sample for you. -
Company History2011 Tianjin Foerhao Pharmaceutical Packaging Co., Ltd. was established by Foerhao Group 2012 Food QS certificate-national production license for industrial products (plastic containers for food) 2013 Pharmaceutical packing material and container register certificate by CFDA 2015 The factory workshop area increased to 20000 ㎡,Warehouse area increased to 13000 ㎡ 2018 We set up a branch office in Canada, mainly responsible for the North American market 2020 Due to the COVID-19, we improve the production capacity and guarantee the supply of Viral Transport Medium.